SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001144204-17-012961
Filing Date
2017-03-06
Accepted
2017-03-06 16:15:20
Documents
5
Period of Report
2017-03-06

Document Format Files

Seq Description Document Type Size
1 PRE 14A v461175_pre14a.htm PRE 14A 345213
2 GRAPHIC pg2img1_pre14a.jpg GRAPHIC 8836
3 GRAPHIC sig_pre14a.jpg GRAPHIC 4021
4 GRAPHIC pg40img1_pre14a.jpg GRAPHIC 292094
5 GRAPHIC pg41img1_pre14a.jpg GRAPHIC 104639
  Complete submission text file 0001144204-17-012961.txt   896214
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33357 | Film No.: 17668054
SIC: 2836 Biological Products, (No Diagnostic Substances)